CompletedNCT00593099
Official study titleA Preliminary Study of Sustained-Release Bupropion for Smoking Cessation in Bipolar Affective Disorder
This study has finished and is no longer accepting participants.
In New HavenBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- National Institute on Drug Abuse (NIDA)
WithdrawnNCT01685151
Official study titleA Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Once a Day, TAK-375SL as an Adjunctive Therapy to Treatment-as-Usual in the Maintenance Treatment of Bipolar 1 Disorder in Adult Subjects
This study was withdrawn before enrollment.
Location not clearly listedBipolarityMedication studyAges 18–75
- Countries
- Sponsor
- Takeda
CompletedNCT00261443
Official study titleEfficacy of Aripiprazole in Combination With Lithium or Valproate in the Long-Term Maintenance Treatment of Bipolar I Disorder in Outpatients Partially Nonresponsive to Lithium or Valproate Monotherapy
This study has finished and is no longer accepting participants.
Multiple locations, including TuscaloosaBipolarityMedication studyAges 18+
- Countries
- United States, France, Brazil, + 6 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
CompletedNCT00741299
Official study titleAssociation Between Tobacco Smoking and Bipolar Affective Disorder.Clinico-epidemiological, Cross-sectional, Retrospective Study.
This study has finished and is no longer accepting participants.
In Tirat HaCarmelBipolarityObservational studyAges 18–65
- Countries
- Israel
- Sponsor
- Tirat Carmel Mental Health Center
CompletedNCT01092221
Official study titleAllopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode.
This study has finished and is no longer accepting participants.
Multiple locations, including Beer-YaakovBipolarityMedication studyAges 18–65
- Countries
- Israel, Romania
- Sponsor
- Sheba Medical Center
CompletedNCT06296784
Official study titleAn E-health Psychoeducation Program to Manage Symptoms During COVID-19 Pandemic for People With Bipolar Disorders: a Randomized Controlled Study
This study has finished and is no longer accepting participants.
In CagliariBipolarityInterventional studyAges 18+
- Countries
- Italy
- Sponsor
- University of Cagliari
CompletedNCT00095511
Official study titleA Multicenter, Randomized, Double-Blind, Placebo Controlled Study of Aripiprazole Monotherapy in the Treatment of Acutely Manic Patients With Bipolar I Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including TuscaloosaBipolarityMedication studyAges 18+
- Countries
- United States
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
TerminatedNCT06423794
What is this study about?Researchers are studying BHV-7000, tracking side effects to assess long-term safety and tolerability in people with bipolarity type I.
This study ended early.
Multiple locations, including BentonvilleBipolarityMedication studyAges 18–75
- Countries
- United States
- Sponsor
- Biohaven Therapeutics Ltd.
CompletedNCT04034147
Official study titleThe Roots of Metacognitive Failures in Bipolar Disorders: Clinical Determinants of the Discrepancy Between Objective and Subjective Cognition in the Versailles FACE-BD Cohort
This study has finished and is no longer accepting participants.
In Le ChesnayBipolarityObservational studyAges 18–65
- Countries
- France
- Sponsor
- Versailles Hospital
CompletedNCT01176825
Official study titleReducing High-Risk Behaviors Among Bipolar Patients Transitioning to Adulthood
This study has finished and is no longer accepting participants.
In BostonBipolarityBehavioural studyAges 18–24
- Countries
- United States
- Sponsor
- Massachusetts General Hospital (Hospital / academic medical center)
CompletedNCT00000439
Official study titleEfficacy of Valproate Maintenance in Bipolar Alcoholics
This study has finished and is no longer accepting participants.
In PittsburghBipolarityMedication studyAges 18–65
- Countries
- United States
- Sponsor
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
CompletedNCT06167577
Official study titleDysbindin-antipsychotics Psychophamarcogenetics: a Mouse-human Translational Study Towards Personalized Healthcare in Bipolar Disorders GR-2016-02362413
This study has finished and is no longer accepting participants.
In MilanBipolarityObservational studyAges 18–65
- Countries
- Italy
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico